News Focus
News Focus
Replies to #81643 on Biotech Values
icon url

GD

07/30/09 1:28 PM

#81657 RE: ghmm #81643

Tyvaso is approved, what is the upside for UTHR?
icon url

genisi

07/30/09 4:30 PM

#81669 RE: ghmm #81643

GENZ really needs the 4000L facility in Belgium to be approved since the Allston facility will no longer produce Myozyme/Lumizyme only Cerezyme and Fabrazyme, so if something goes wrong there you'll get your big hit.
On being aggressive - PLX people can tell you how aggressive GENZ can be.